Community Member
3 years agoOncotype DX Question Can anyone definitively give me an answer regarding the distant recurrence percentage on the oncotype dx test. The percentage is given with TAM (Tamoxifen) alone. The Radiologist oncologist didn’t know if that percentage included radiation. The Medical Oncologist said the percentage was Tamoxifen and Radiation. No where on the results report does spell out a rate of distant recurrence with ET and Radiation. I was also told that I would have anastrezole so that would lower my risk a little more than tamoxifen. Some clarification would be great.
Accepted Answer
The confusion about what treatments are included in Oncotype DX recurrence percentages is very common, and it's understandable that different doctors might explain it differently. The test typically provides risk estimates based on specific treatment scenarios, but the details can vary depending on which version of the report and which specific numbers are being referenced. Since oncologists have access to additional clinical data and interpretation guidelines that aren't always clearly shown on patient reports, it would be helpful to ask for written clarification from the medical oncologist's office about exactly which treatments are factored into your specific recurrence percentage and how switching to anastrozole might affect those numbers.
3+ patients found this helpful
Community Member
9 months agoHi Rebecca! Your Oncotype is just a percentage estimate looking at a population of patients that had standard of care treatment so that included radiation for some but not all. Most had Tamoxifen and not an AI so your MO is right that might mean your risk on an AI is less. When risk reduction is given for radiation it’s generally for reducing the chances of a local recurrence and not for distant recurrence which is what your oncotype report provides. So unfortunately you can’t really assume your % is less due to the addition of radiation. Hope that helps!
Community Member
9 months agoThanks, that does help to clarify.
Community Member
4 months agoThe confusion about what treatments are included in Oncotype DX recurrence percentages is very common, and it's understandable that different doctors might explain it differently. The test typically provides risk estimates based on specific treatment scenarios, but the details can vary depending on which version of the report and which specific numbers are being referenced. Since oncologists have access to additional clinical data and interpretation guidelines that aren't always clearly shown on patient reports, it would be helpful to ask for written clarification from the medical oncologist's office about exactly which treatments are factored into your specific recurrence percentage and how switching to anastrozole might affect those numbers.
New to the community?
Create an account to connect with others navigating cancer.
© 2026 Outcomes4Me Inc. All rights reserved.